Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2002-08-27

AUTHORS

F Maire, S Micard, P Hammel, H Voitot, P Lévy, P-H Cugnenc, P Ruszniewski, P Laurent Puig

ABSTRACT

KRAS2 mutations in codon 12 have been detected in about 80% of pancreatic cancers. The aim of this study was to evaluate the value of KRAS2 mutations detection in circulating deoxyribo nucleic acid to differentiate pancreatic cancer from chronic pancreatitis. Circulating deoxyribonucleic acid was isolated from serum in 47 patients with histologically proven pancreatic adenocarcinomas (26 males, median age 65 years) and 31 controls with chronic pancreatitis (26 males, median age 48 years). Mutations at codon 12 of KRAS2 gene were searched for using polymerase chain reaction and allele specific amplification. Serum carbohydrate antigen 19.9 levels were also determined. KRAS2 mutations were found in 22 patients (47%) with pancreatic cancer and in four controls with chronic pancreatitis (13%) (P<0.002). None of the latter developed a pancreatic cancer within the 36 months of median follow-up. The sensitivity, specificity, positive and negative predictive values of serum serum KRAS2 mutations for the diagnosis of pancreatic cancer were 47, 87, 85 and 52%, respectively. KRAS2 mutations were not related to age, gender, smoking habit, tumour stage, or survival. Among the 26 patients with normal or non-contributive (due to cholestasis) serum carbohydrate antigen 19.9 levels, 14 (54%) had KRAS2 mutations. The combination of KRAS2 and carbohydrate antigen 19.9 gave a sensitivity, specificity, positive and negative predictive values for the diagnosis of pancreatic cancer of 98, 77, 87 and 96%, respectively. Detection of KRAS2 mutations in circulating deoxyribo nucleic acid has a low sensitivity but a specificity about 90% for the diagnosis of pancreatic cancer. It seems particularly useful when serum carbohydrate antigen 19.9 levels are normal or inconclusive. A combined normal serum carbohydrate antigen 19.9 and absence of circulating KRAS2 mutations makes the diagnosis of pancreatic cancer extremely unlikely. More... »

PAGES

551-554

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6600475

DOI

http://dx.doi.org/10.1038/sj.bjc.6600475

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029325429

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12189555


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alleles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CA-19-9 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chronic Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Codon", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Mutational Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Amplification", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, ras", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplastic Cells, Circulating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Smoking", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "F\u00e9d\u00e9ration M\u00e9dico-Chirurgicale d'H\u00e9pato-Gastroent\u00e9rologie, H\u00f4pital Beaujon, AP-HP, 92110 Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "F\u00e9d\u00e9ration M\u00e9dico-Chirurgicale d'H\u00e9pato-Gastroent\u00e9rologie, H\u00f4pital Beaujon, AP-HP, 92110 Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maire", 
        "givenName": "F", 
        "id": "sg:person.01351504544.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351504544.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "U490 INSERM Laboratoire de Toxicologie Mol\u00e9culaire, 45 rue des Saints-P\u00e8res 75006 Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "U490 INSERM Laboratoire de Toxicologie Mol\u00e9culaire, 45 rue des Saints-P\u00e8res 75006 Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Micard", 
        "givenName": "S", 
        "id": "sg:person.01334243037.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334243037.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "F\u00e9d\u00e9ration M\u00e9dico-Chirurgicale d'H\u00e9pato-Gastroent\u00e9rologie, H\u00f4pital Beaujon, AP-HP, 92110 Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "F\u00e9d\u00e9ration M\u00e9dico-Chirurgicale d'H\u00e9pato-Gastroent\u00e9rologie, H\u00f4pital Beaujon, AP-HP, 92110 Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hammel", 
        "givenName": "P", 
        "id": "sg:person.01355345644.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355345644.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire de Biochimie, H\u00f4pital Beaujon, 92110 Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "Laboratoire de Biochimie, H\u00f4pital Beaujon, 92110 Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Voitot", 
        "givenName": "H", 
        "id": "sg:person.01310130627.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310130627.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "F\u00e9d\u00e9ration M\u00e9dico-Chirurgicale d'H\u00e9pato-Gastroent\u00e9rologie, H\u00f4pital Beaujon, AP-HP, 92110 Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "F\u00e9d\u00e9ration M\u00e9dico-Chirurgicale d'H\u00e9pato-Gastroent\u00e9rologie, H\u00f4pital Beaujon, AP-HP, 92110 Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "L\u00e9vy", 
        "givenName": "P", 
        "id": "sg:person.0740232450.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740232450.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de Chirurgie Digestive et Oncologie, H\u00f4pital Europ\u00e9en Georges Pompidou, 75015 Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.414093.b", 
          "name": [
            "Service de Chirurgie Digestive et Oncologie, H\u00f4pital Europ\u00e9en Georges Pompidou, 75015 Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cugnenc", 
        "givenName": "P-H", 
        "id": "sg:person.0740311470.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740311470.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "F\u00e9d\u00e9ration M\u00e9dico-Chirurgicale d'H\u00e9pato-Gastroent\u00e9rologie, H\u00f4pital Beaujon, AP-HP, 92110 Clichy, France", 
          "id": "http://www.grid.ac/institutes/grid.411599.1", 
          "name": [
            "F\u00e9d\u00e9ration M\u00e9dico-Chirurgicale d'H\u00e9pato-Gastroent\u00e9rologie, H\u00f4pital Beaujon, AP-HP, 92110 Clichy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ruszniewski", 
        "givenName": "P", 
        "id": "sg:person.0640551545.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640551545.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de Chirurgie Digestive et Oncologie, H\u00f4pital Europ\u00e9en Georges Pompidou, 75015 Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.414093.b", 
          "name": [
            "U490 INSERM Laboratoire de Toxicologie Mol\u00e9culaire, 45 rue des Saints-P\u00e8res 75006 Paris, France", 
            "Service de Chirurgie Digestive et Oncologie, H\u00f4pital Europ\u00e9en Georges Pompidou, 75015 Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Puig", 
        "givenName": "P Laurent", 
        "id": "sg:person.01030301316.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030301316.35"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s004230050189", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029486276", 
          "https://doi.org/10.1007/s004230050189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1572-0241.2001.03608.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048681260", 
          "https://doi.org/10.1111/j.1572-0241.2001.03608.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02825415", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082427428", 
          "https://doi.org/10.1007/bf02825415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1018803532543", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048044011", 
          "https://doi.org/10.1023/a:1018803532543"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2002-08-27", 
    "datePublishedReg": "2002-08-27", 
    "description": "KRAS2 mutations in codon 12 have been detected in about 80% of pancreatic cancers. The aim of this study was to evaluate the value of KRAS2 mutations detection in circulating deoxyribo nucleic acid to differentiate pancreatic cancer from chronic pancreatitis. Circulating deoxyribonucleic acid was isolated from serum in 47 patients with histologically proven pancreatic adenocarcinomas (26 males, median age 65 years) and 31 controls with chronic pancreatitis (26 males, median age 48 years). Mutations at codon 12 of KRAS2 gene were searched for using polymerase chain reaction and allele specific amplification. Serum carbohydrate antigen 19.9 levels were also determined. KRAS2 mutations were found in 22 patients (47%) with pancreatic cancer and in four controls with chronic pancreatitis (13%) (P<0.002). None of the latter developed a pancreatic cancer within the 36 months of median follow-up. The sensitivity, specificity, positive and negative predictive values of serum serum KRAS2 mutations for the diagnosis of pancreatic cancer were 47, 87, 85 and 52%, respectively. KRAS2 mutations were not related to age, gender, smoking habit, tumour stage, or survival. Among the 26 patients with normal or non-contributive (due to cholestasis) serum carbohydrate antigen 19.9 levels, 14 (54%) had KRAS2 mutations. The combination of KRAS2 and carbohydrate antigen 19.9 gave a sensitivity, specificity, positive and negative predictive values for the diagnosis of pancreatic cancer of 98, 77, 87 and 96%, respectively. Detection of KRAS2 mutations in circulating deoxyribo nucleic acid has a low sensitivity but a specificity about 90% for the diagnosis of pancreatic cancer. It seems particularly useful when serum carbohydrate antigen 19.9 levels are normal or inconclusive. A combined normal serum carbohydrate antigen 19.9 and absence of circulating KRAS2 mutations makes the diagnosis of pancreatic cancer extremely unlikely.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6600475", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "87"
      }
    ], 
    "keywords": [
      "carbohydrate antigen 19.9", 
      "pancreatic cancer", 
      "chronic pancreatitis", 
      "negative predictive value", 
      "KRAS2 mutations", 
      "antigen 19.9", 
      "predictive value", 
      "codon 12", 
      "smoking habits", 
      "tumor stage", 
      "pancreatic adenocarcinoma", 
      "polymerase chain reaction", 
      "differential diagnosis", 
      "pancreatitis", 
      "cancer", 
      "patients", 
      "diagnosis", 
      "chain reaction", 
      "allele-specific amplification", 
      "Kras2 gene", 
      "low sensitivity", 
      "nucleic acids", 
      "mutations", 
      "specificity", 
      "mutation detection", 
      "adenocarcinoma", 
      "levels", 
      "deoxyribonucleic acid", 
      "serum", 
      "months", 
      "survival", 
      "sensitivity", 
      "age", 
      "specific amplification", 
      "KRAS2", 
      "control", 
      "acid", 
      "gender", 
      "aim", 
      "habits", 
      "detection", 
      "absence", 
      "deoxyribo nucleic acid", 
      "study", 
      "genes", 
      "values", 
      "amplification", 
      "stage", 
      "combination", 
      "DNA", 
      "reaction", 
      "KRAS2 mutations detection", 
      "serum carbohydrate antigen 19.9 levels", 
      "carbohydrate antigen 19.9 levels", 
      "antigen 19.9 levels", 
      "serum serum KRAS2 mutations", 
      "serum KRAS2 mutations", 
      "non-contributive (due to cholestasis) serum carbohydrate antigen 19.9 levels", 
      "combination of KRAS2", 
      "combined normal serum carbohydrate antigen 19.9", 
      "normal serum carbohydrate antigen 19.9", 
      "serum carbohydrate antigen 19.9"
    ], 
    "name": "Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA", 
    "pagination": "551-554", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029325429"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6600475"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12189555"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6600475", 
      "https://app.dimensions.ai/details/publication/pub.1029325429"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_362.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6600475"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600475'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600475'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600475'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600475'


 

This table displays all metadata directly associated to this object as RDF triples.

298 TRIPLES      22 PREDICATES      117 URIs      105 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6600475 schema:about N134be2dfc2e84b9ab534f03afaec2b20
2 N1772906a40164eaeb774996deeb5530c
3 N17b6428156cc4d809084dd60427a7158
4 N2b6ef38754584b1a81f6f9ffe78478f3
5 N31a405cd2ffd42f1930a7c567a83f45d
6 N4ec50d4a2a0a403ebb3fe6b5a8c1173b
7 N5d56fd192b884a9094850dd8cd63c4b4
8 N6413ebf21f6441caa3829dbc6d3bcbfa
9 N6541469abed0404b94bcc3047fa28ab0
10 N7febaafe3cf94945b741be7590b8f0f8
11 N805b5d8377ea4268beb35d56d4c464f6
12 N8399002943b947858bb8a7db791deaff
13 N8febefe1c85342d4b0de45d1c51c46c2
14 N9b1b67c7b125477a9ba58e171b0b1fed
15 Na5b81846d1a1440a96e66f5d8985155d
16 Nadce73bf51bb44caa89938b6483bfb5c
17 Nbb4814f7eb2143f6a66f1a9c55fc33ff
18 Nc5c94f3b43c04dce8310408e024e699f
19 Nce88f2a076d24db5952f58b6aaec0f8d
20 Ne426dd7e8e2840be88200ad2ecb23a44
21 Ne46fbc19b31845a6b74404f2bc797a4d
22 Ne588809049df4de48f1de1c4ee6a1f3b
23 Ned6bb45f44b74ec2bebcb9be2a0bdb49
24 Nf424eaf6ab1e43baa3462cd4de387c7c
25 Nf427b55596e04d5d987fc87adc9a4e50
26 anzsrc-for:11
27 anzsrc-for:1112
28 schema:author Nbba37b07928e4f449a979fd852c7fa29
29 schema:citation sg:pub.10.1007/bf02825415
30 sg:pub.10.1007/s004230050189
31 sg:pub.10.1023/a:1018803532543
32 sg:pub.10.1111/j.1572-0241.2001.03608.x
33 schema:datePublished 2002-08-27
34 schema:datePublishedReg 2002-08-27
35 schema:description KRAS2 mutations in codon 12 have been detected in about 80% of pancreatic cancers. The aim of this study was to evaluate the value of KRAS2 mutations detection in circulating deoxyribo nucleic acid to differentiate pancreatic cancer from chronic pancreatitis. Circulating deoxyribonucleic acid was isolated from serum in 47 patients with histologically proven pancreatic adenocarcinomas (26 males, median age 65 years) and 31 controls with chronic pancreatitis (26 males, median age 48 years). Mutations at codon 12 of KRAS2 gene were searched for using polymerase chain reaction and allele specific amplification. Serum carbohydrate antigen 19.9 levels were also determined. KRAS2 mutations were found in 22 patients (47%) with pancreatic cancer and in four controls with chronic pancreatitis (13%) (P<0.002). None of the latter developed a pancreatic cancer within the 36 months of median follow-up. The sensitivity, specificity, positive and negative predictive values of serum serum KRAS2 mutations for the diagnosis of pancreatic cancer were 47, 87, 85 and 52%, respectively. KRAS2 mutations were not related to age, gender, smoking habit, tumour stage, or survival. Among the 26 patients with normal or non-contributive (due to cholestasis) serum carbohydrate antigen 19.9 levels, 14 (54%) had KRAS2 mutations. The combination of KRAS2 and carbohydrate antigen 19.9 gave a sensitivity, specificity, positive and negative predictive values for the diagnosis of pancreatic cancer of 98, 77, 87 and 96%, respectively. Detection of KRAS2 mutations in circulating deoxyribo nucleic acid has a low sensitivity but a specificity about 90% for the diagnosis of pancreatic cancer. It seems particularly useful when serum carbohydrate antigen 19.9 levels are normal or inconclusive. A combined normal serum carbohydrate antigen 19.9 and absence of circulating KRAS2 mutations makes the diagnosis of pancreatic cancer extremely unlikely.
36 schema:genre article
37 schema:inLanguage en
38 schema:isAccessibleForFree true
39 schema:isPartOf N2569838432254637b7e89a82c077dc65
40 N53505ffb1d484737b50c7f8c95dee0f9
41 sg:journal.1017082
42 schema:keywords DNA
43 KRAS2
44 KRAS2 mutations
45 KRAS2 mutations detection
46 Kras2 gene
47 absence
48 acid
49 adenocarcinoma
50 age
51 aim
52 allele-specific amplification
53 amplification
54 antigen 19.9
55 antigen 19.9 levels
56 cancer
57 carbohydrate antigen 19.9
58 carbohydrate antigen 19.9 levels
59 chain reaction
60 chronic pancreatitis
61 codon 12
62 combination
63 combination of KRAS2
64 combined normal serum carbohydrate antigen 19.9
65 control
66 deoxyribo nucleic acid
67 deoxyribonucleic acid
68 detection
69 diagnosis
70 differential diagnosis
71 gender
72 genes
73 habits
74 levels
75 low sensitivity
76 months
77 mutation detection
78 mutations
79 negative predictive value
80 non-contributive (due to cholestasis) serum carbohydrate antigen 19.9 levels
81 normal serum carbohydrate antigen 19.9
82 nucleic acids
83 pancreatic adenocarcinoma
84 pancreatic cancer
85 pancreatitis
86 patients
87 polymerase chain reaction
88 predictive value
89 reaction
90 sensitivity
91 serum
92 serum KRAS2 mutations
93 serum carbohydrate antigen 19.9
94 serum carbohydrate antigen 19.9 levels
95 serum serum KRAS2 mutations
96 smoking habits
97 specific amplification
98 specificity
99 stage
100 study
101 survival
102 tumor stage
103 values
104 schema:name Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA
105 schema:pagination 551-554
106 schema:productId N0dc0a85fcc694f9488965c65fccf183b
107 N406e2b069033401080637447b79e5d3d
108 N87fbf1b36e684590924c0a017332f20e
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029325429
110 https://doi.org/10.1038/sj.bjc.6600475
111 schema:sdDatePublished 2022-01-01T18:12
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher Nec2966f999824fdf8dac66486c91361a
114 schema:url https://doi.org/10.1038/sj.bjc.6600475
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N0dc0a85fcc694f9488965c65fccf183b schema:name doi
119 schema:value 10.1038/sj.bjc.6600475
120 rdf:type schema:PropertyValue
121 N134be2dfc2e84b9ab534f03afaec2b20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Aged, 80 and over
123 rdf:type schema:DefinedTerm
124 N1772906a40164eaeb774996deeb5530c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Aged
126 rdf:type schema:DefinedTerm
127 N17b6428156cc4d809084dd60427a7158 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Adenocarcinoma
129 rdf:type schema:DefinedTerm
130 N2569838432254637b7e89a82c077dc65 schema:volumeNumber 87
131 rdf:type schema:PublicationVolume
132 N2b6ef38754584b1a81f6f9ffe78478f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Male
134 rdf:type schema:DefinedTerm
135 N31a405cd2ffd42f1930a7c567a83f45d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Survival Analysis
137 rdf:type schema:DefinedTerm
138 N406e2b069033401080637447b79e5d3d schema:name pubmed_id
139 schema:value 12189555
140 rdf:type schema:PropertyValue
141 N46728c9cbd4b4ba9a6ddff91f14baddb rdf:first sg:person.01310130627.51
142 rdf:rest Nc8af26bd287f4f3da1ebb35abcc85bcb
143 N4ec50d4a2a0a403ebb3fe6b5a8c1173b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name DNA
145 rdf:type schema:DefinedTerm
146 N53505ffb1d484737b50c7f8c95dee0f9 schema:issueNumber 5
147 rdf:type schema:PublicationIssue
148 N5d56fd192b884a9094850dd8cd63c4b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Biomarkers, Tumor
150 rdf:type schema:DefinedTerm
151 N6413ebf21f6441caa3829dbc6d3bcbfa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Female
153 rdf:type schema:DefinedTerm
154 N6541469abed0404b94bcc3047fa28ab0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Humans
156 rdf:type schema:DefinedTerm
157 N6f90a41c911348a0bdcea28bb5272a39 rdf:first sg:person.0740311470.12
158 rdf:rest Na178de2d5cf1467bade031b08d0aad7a
159 N7febaafe3cf94945b741be7590b8f0f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Pancreatitis
161 rdf:type schema:DefinedTerm
162 N805b5d8377ea4268beb35d56d4c464f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name CA-19-9 Antigen
164 rdf:type schema:DefinedTerm
165 N8399002943b947858bb8a7db791deaff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Follow-Up Studies
167 rdf:type schema:DefinedTerm
168 N87fbf1b36e684590924c0a017332f20e schema:name dimensions_id
169 schema:value pub.1029325429
170 rdf:type schema:PropertyValue
171 N8febefe1c85342d4b0de45d1c51c46c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Middle Aged
173 rdf:type schema:DefinedTerm
174 N9b1b67c7b125477a9ba58e171b0b1fed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Pancreatic Neoplasms
176 rdf:type schema:DefinedTerm
177 Na178de2d5cf1467bade031b08d0aad7a rdf:first sg:person.0640551545.21
178 rdf:rest Nddd20111a6c244068ca7325c028eb24c
179 Na5b81846d1a1440a96e66f5d8985155d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Polymerase Chain Reaction
181 rdf:type schema:DefinedTerm
182 Nadce73bf51bb44caa89938b6483bfb5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name DNA Mutational Analysis
184 rdf:type schema:DefinedTerm
185 Nbb4814f7eb2143f6a66f1a9c55fc33ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Genes, ras
187 rdf:type schema:DefinedTerm
188 Nbba37b07928e4f449a979fd852c7fa29 rdf:first sg:person.01351504544.65
189 rdf:rest Ne2e1c3c9f49648a190eecfbd12f4e685
190 Nc5c94f3b43c04dce8310408e024e699f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Chronic Disease
192 rdf:type schema:DefinedTerm
193 Nc8af26bd287f4f3da1ebb35abcc85bcb rdf:first sg:person.0740232450.15
194 rdf:rest N6f90a41c911348a0bdcea28bb5272a39
195 Nce88f2a076d24db5952f58b6aaec0f8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Predictive Value of Tests
197 rdf:type schema:DefinedTerm
198 Nddd20111a6c244068ca7325c028eb24c rdf:first sg:person.01030301316.35
199 rdf:rest rdf:nil
200 Ne2e1c3c9f49648a190eecfbd12f4e685 rdf:first sg:person.01334243037.73
201 rdf:rest Nf0fe2af417264b68aefa52b4dd3dfebd
202 Ne426dd7e8e2840be88200ad2ecb23a44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Codon
204 rdf:type schema:DefinedTerm
205 Ne46fbc19b31845a6b74404f2bc797a4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Neoplastic Cells, Circulating
207 rdf:type schema:DefinedTerm
208 Ne588809049df4de48f1de1c4ee6a1f3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Sensitivity and Specificity
210 rdf:type schema:DefinedTerm
211 Nec2966f999824fdf8dac66486c91361a schema:name Springer Nature - SN SciGraph project
212 rdf:type schema:Organization
213 Ned6bb45f44b74ec2bebcb9be2a0bdb49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Smoking
215 rdf:type schema:DefinedTerm
216 Nf0fe2af417264b68aefa52b4dd3dfebd rdf:first sg:person.01355345644.55
217 rdf:rest N46728c9cbd4b4ba9a6ddff91f14baddb
218 Nf424eaf6ab1e43baa3462cd4de387c7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
219 schema:name Alleles
220 rdf:type schema:DefinedTerm
221 Nf427b55596e04d5d987fc87adc9a4e50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
222 schema:name Gene Amplification
223 rdf:type schema:DefinedTerm
224 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
225 schema:name Medical and Health Sciences
226 rdf:type schema:DefinedTerm
227 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
228 schema:name Oncology and Carcinogenesis
229 rdf:type schema:DefinedTerm
230 sg:journal.1017082 schema:issn 0007-0920
231 1532-1827
232 schema:name British Journal of Cancer
233 schema:publisher Springer Nature
234 rdf:type schema:Periodical
235 sg:person.01030301316.35 schema:affiliation grid-institutes:grid.414093.b
236 schema:familyName Puig
237 schema:givenName P Laurent
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030301316.35
239 rdf:type schema:Person
240 sg:person.01310130627.51 schema:affiliation grid-institutes:grid.411599.1
241 schema:familyName Voitot
242 schema:givenName H
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310130627.51
244 rdf:type schema:Person
245 sg:person.01334243037.73 schema:affiliation grid-institutes:None
246 schema:familyName Micard
247 schema:givenName S
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334243037.73
249 rdf:type schema:Person
250 sg:person.01351504544.65 schema:affiliation grid-institutes:grid.411599.1
251 schema:familyName Maire
252 schema:givenName F
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351504544.65
254 rdf:type schema:Person
255 sg:person.01355345644.55 schema:affiliation grid-institutes:grid.411599.1
256 schema:familyName Hammel
257 schema:givenName P
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355345644.55
259 rdf:type schema:Person
260 sg:person.0640551545.21 schema:affiliation grid-institutes:grid.411599.1
261 schema:familyName Ruszniewski
262 schema:givenName P
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640551545.21
264 rdf:type schema:Person
265 sg:person.0740232450.15 schema:affiliation grid-institutes:grid.411599.1
266 schema:familyName Lévy
267 schema:givenName P
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740232450.15
269 rdf:type schema:Person
270 sg:person.0740311470.12 schema:affiliation grid-institutes:grid.414093.b
271 schema:familyName Cugnenc
272 schema:givenName P-H
273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740311470.12
274 rdf:type schema:Person
275 sg:pub.10.1007/bf02825415 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082427428
276 https://doi.org/10.1007/bf02825415
277 rdf:type schema:CreativeWork
278 sg:pub.10.1007/s004230050189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029486276
279 https://doi.org/10.1007/s004230050189
280 rdf:type schema:CreativeWork
281 sg:pub.10.1023/a:1018803532543 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048044011
282 https://doi.org/10.1023/a:1018803532543
283 rdf:type schema:CreativeWork
284 sg:pub.10.1111/j.1572-0241.2001.03608.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1048681260
285 https://doi.org/10.1111/j.1572-0241.2001.03608.x
286 rdf:type schema:CreativeWork
287 grid-institutes:None schema:alternateName U490 INSERM Laboratoire de Toxicologie Moléculaire, 45 rue des Saints-Pères 75006 Paris, France
288 schema:name U490 INSERM Laboratoire de Toxicologie Moléculaire, 45 rue des Saints-Pères 75006 Paris, France
289 rdf:type schema:Organization
290 grid-institutes:grid.411599.1 schema:alternateName Fédération Médico-Chirurgicale d'Hépato-Gastroentérologie, Hôpital Beaujon, AP-HP, 92110 Clichy, France
291 Laboratoire de Biochimie, Hôpital Beaujon, 92110 Clichy, France
292 schema:name Fédération Médico-Chirurgicale d'Hépato-Gastroentérologie, Hôpital Beaujon, AP-HP, 92110 Clichy, France
293 Laboratoire de Biochimie, Hôpital Beaujon, 92110 Clichy, France
294 rdf:type schema:Organization
295 grid-institutes:grid.414093.b schema:alternateName Service de Chirurgie Digestive et Oncologie, Hôpital Européen Georges Pompidou, 75015 Paris, France
296 schema:name Service de Chirurgie Digestive et Oncologie, Hôpital Européen Georges Pompidou, 75015 Paris, France
297 U490 INSERM Laboratoire de Toxicologie Moléculaire, 45 rue des Saints-Pères 75006 Paris, France
298 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...